Overview
Autonomic disorders caused by organic solvent exposure arise from the systemic effects of volatile chemicals that preferentially accumulate in adipose tissues, leading to neurotoxic manifestations 1.Diagnosis
Exposure Assessment: Evaluate history of organic solvent exposure 1.
Metabolite Analysis: Measure urinary metabolites using colorimetry, gas chromatography, or high-performance liquid chromatography for confirmation 2.
Clinical Evaluation: Assess autonomic symptoms including orthostatic hypotension, sweating abnormalities, and gastrointestinal disturbances 1.Management
Removal from Exposure: Immediate cessation of exposure to the causative solvent 1.
Supportive Care: Manage symptoms with physical therapy, orthostatic training, and medications for specific symptoms (e.g., fludrocortisone for hypotension) 1.
Monitoring: Regular follow-up to assess recovery and adjust supportive therapies as needed 1.Special Populations
Pregnancy: Limited data; prioritize minimizing exposure and close monitoring of maternal and fetal health 1.
Pediatrics: Increased vulnerability due to developing systems; strict avoidance and vigilant symptom monitoring are crucial 1.
Elderly: Consider age-related comorbidities that may exacerbate autonomic dysfunction; tailored supportive care is essential 1.Key Recommendations
Identify and Remove Exposure: Promptly identify and eliminate exposure to organic solvents to halt further toxicity (Evidence: Strong 1).
Utilize Urinary Metabolite Testing: Employ validated methods such as gas chromatography or high-performance liquid chromatography for confirming exposure through metabolite analysis (Evidence: Moderate 2).
Implement Supportive Symptom Management: Provide symptomatic treatment tailored to the patient’s needs, including physical therapy and pharmacological interventions as appropriate (Evidence: Expert opinion 1).References
1 Sato A, Nakajima T. Pharmacokinetics of organic solvent vapors in relation to their toxicity. Scandinavian journal of work, environment & health 1987. link
2 Ogata M. Quantitative determination of urinary metabolites in subjects exposed to organic solvents. Acta medica Okayama 1981. link